St a r t a f re e a s s e s s m e nt a t
n oz i n . c o m /n ova
PROTECT EVERY PATIENT
SM
*Outcomes reported by actual customers. Your results may vary. References: nozin. com/clinical-outcomes. ©2024 Global Life Technologies Corp. All rights reserved. Made in USA. Nozin
®
,
Nasal Sanitizer
®
, Protect Every Patient
SM
, and NOVA
SM
are trademarks of Global Life Technologies Corp. Other trademarks are property of their respective owners. Nozin
®
Nasal Sanitizer
®
antiseptic is an OTC topical drug intended to decrease bacteria on nasal vestibule skin. No claim is made that it has an effect on any specific disease. Patent nos.: nozin.com/patents.
REDUCE RISK OF AVOIDABLE INFECTIONS
AND ASSOCIATED EXCESS LENGTH OF STAY
Nasal colonization is a primary risk factor for healthcare-
associated infections (HAIs). The new patient safety paradigm
is to make universal nasal decolonization the standard of care,
without using antibiotics. This is our Protect Every Patient
SM
service mission to help with your hospital IP program.
In published studies, hospitals using Nozin NOVA
SM
programs
powered by Nozin
®
Nasal Sanitizer
®
antiseptic report lower
infections and significant cost savings. Learn more about
how we can help. Start with a no cost risk assessment today.
